logo
Select company
Select metric
12.84%Cash to Assets Ratio
VS
Market
63
Sector
30
Industry
16
History
45
$ 6.52Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information

Ticker

ICCC

Company Name

IMMUCELL CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMUCELL CORP - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ICCC - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 46.72M$ 6M12.84%
3/31/2025$ 45.62M$ 4.6M10.08%
12/31/2024$ 45.1M$ 3.76M8.33%
9/30/2024$ 44.45M$ 3.81M8.57%
6/30/2024$ 41.86M$ 1.32M3.16%
3/31/2024$ 43.05M$ 960.35K2.23%
12/31/2023$ 43.81M$ 978.74K2.23%
9/30/2023$ 44.55M$ 1.99M4.47%
6/30/2023$ 44.01M$ 1.45M3.3%
3/31/2023$ 43.12M$ 3.1M7.18%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMMUCELL CORP's latest trailing twelve months (TTM) Cash to Assets stands at 13.3%.
  • Over the past 5 years, IMMUCELL CORP's average Cash to Assets has been 13.12%.
  • The median Cash to Assets for IMMUCELL CORP during this period was 12.87%
  • IMMUCELL CORP reached its highest Cash to Assets over the past 5 years at 25.3%.
  • The lowest Cash to Assets recorded by IMMUCELL CORP in the same timeframe 2.23%

IMMUCELL CORP's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
MGX : METAGENOMI INC 11.79%EQ : EQUILLIUM INC 92.71%BRNS : BARINTHUS BIOTHERAPEUTICS PLC 67.75%IRD : OPUS GENETICS INC 83.87%VRCA : VERRICA PHARMACEUTICALS INC 39.37%WHWK : WHITEHAWK THERAPEUTICS INC 80.15%MRSN : MERSANA THERAPEUTICS INC 91.01%MDAI : SPECTRAL AI INC 65.74%CUE : CUE BIOPHARMA INC 72.72%FORA : FORIAN INC 11.08%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for IMMUCELL CORP is calculated as follows: CashnEq [ $ 5.32M ] / Assets [ $ 39.99M ]
(=) Cash to Assets [ 13.3% ]

ICCC - Cash to Assets Ratio, Last 5 years

2.23%

Minimum

Mar 31, 2024

25.3%

Maximum

Mar 31, 2022

13.12%

Average

12.87%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%